Daniel Faga, the President of $ANAB, sold 3,155 shares of the company on 03-27-2026 for an estimated $202,522. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.6% of their shares of this class of stock. Following this trade, they now own 499,103 shares of this class of $ANAB stock.
$ANAB Insider Trading Activity
$ANAB insiders have traded $ANAB stock on the open market 39 times in the past 6 months. Of those trades, 0 have been purchases and 39 have been sales.
Here’s a breakdown of recent trading of $ANAB stock by insiders over the last 6 months:
- ERIC J LOUMEAU (CHIEF LEGAL OFFICER) has made 0 purchases and 13 sales selling 65,713 shares for an estimated $2,983,438.
- DANIEL FAGA (President, CEO) has made 0 purchases and 13 sales selling 56,471 shares for an estimated $2,805,071.
- DENNIS MULROY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 6 sales selling 33,511 shares for an estimated $1,549,331.
- MAGDA MARQUET has made 0 purchases and 2 sales selling 11,000 shares for an estimated $530,531.
- PAUL F. LIZZUL (Chief Medical Officer) has made 0 purchases and 4 sales selling 11,604 shares for an estimated $521,526.
- J. ANTHONY WARE sold 3,900 shares for an estimated $193,342
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ANAB Hedge Fund Activity
We have seen 86 institutional investors add shares of $ANAB stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ASSENAGON ASSET MANAGEMENT S.A. removed 839,934 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $40,720,000
- MILLENNIUM MANAGEMENT LLC removed 705,659 shares (-46.4%) from their portfolio in Q4 2025, for an estimated $34,210,348
- MORGAN STANLEY removed 521,696 shares (-33.5%) from their portfolio in Q4 2025, for an estimated $25,291,822
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 491,040 shares (-78.4%) from their portfolio in Q4 2025, for an estimated $23,805,619
- AFFINITY ASSET ADVISORS, LLC added 444,692 shares (+inf%) to their portfolio in Q4 2025, for an estimated $21,558,668
- FIRST LIGHT ASSET MANAGEMENT, LLC removed 343,923 shares (-34.7%) from their portfolio in Q4 2025, for an estimated $16,673,387
- POINT72 ASSET MANAGEMENT, L.P. removed 332,638 shares (-14.7%) from their portfolio in Q4 2025, for an estimated $16,126,290
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ANAB Analyst Ratings
Wall Street analysts have issued reports on $ANAB in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/20/2026
- UBS issued a "Buy" rating on 01/07/2026
- Stifel issued a "Buy" rating on 12/11/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/24/2025
- Wedbush issued a "Outperform" rating on 11/24/2025
To track analyst ratings and price targets for $ANAB, check out Quiver Quantitative's $ANAB forecast page.
$ANAB Price Targets
Multiple analysts have issued price targets for $ANAB recently. We have seen 9 analysts offer price targets for $ANAB in the last 6 months, with a median target of $79.0.
Here are some recent targets:
- Michael Yee from UBS set a target price of $90.0 on 03/17/2026
- Martin Fan from Wedbush set a target price of $75.0 on 03/12/2026
- John Lee from Truist Securities set a target price of $50.0 on 03/09/2026
- Alex Thompson from Stifel set a target price of $85.0 on 03/05/2026
- Emily Bodnar from HC Wainwright & Co. set a target price of $66.0 on 03/04/2026
- Etzer Darout from Barclays set a target price of $79.0 on 03/04/2026
- Derek Archila from Wells Fargo set a target price of $81.0 on 11/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
